Abstract
Objective:We investigated the thrombotic microenvironment at the very early stages of Type 2 Diabetes Mellitus (T2DM) by measuring Platelet-derived Microvesicles (PMVs) and Erythrocyte-derived Microvesicles (ErMVs) in newly-diagnosed patients. Microvesicles (MVs) are small, membrane vesicles (0.1 to
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.